𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Serum EGFR and serum HER2 in patients with triple negative breast cancer

✍ Scribed by R. Iosifidou; G. Galaktidou; X.R. Albanaki; S. Mameletzi; N. Vladika; F. Patakiouta; A. Bousoulegas

Book ID
119598799
Publisher
Elsevier Science
Year
2008
Tongue
English
Weight
88 KB
Volume
6
Category
Article
ISSN
1359-6349

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Serum EGFR and serum HER-2/neu are usefu
Serum EGFR and serum HER-2/neu are useful predictive and prognostic markers in metastatic breast cancer patients treated with metronomic chemotherapy
✍ Maria Teresa Sandri; Harriet Ann Johansson; Laura Zorzino; Michela Salvatici; Ri πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 127 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Metronomic chemotherapy has been demonstrated to be of value in patients with advanced breast cancer. No reliable markers of response are available. In breast tumor, HER‐2/__neu__ is a prognostic factor, whereas no definite data exist for EGFR. The aim of the study was t